tiprankstipranks
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX

Celldex (CLDX) Financial Statements

993 Followers

Celldex Financial Overview

Celldex's market cap is currently ―. The company's EPS TTM is $-2.844; its P/E ratio is -12.92; Celldex is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 156.00K$ 4.13M$ 1.52M$ 268.00K$ 967.00K
Gross Profit$ 156.00K$ 4.13M$ 1.52M$ 268.00K$ 967.00K
EBIT$ -40.61M$ -35.13M$ -38.26M$ -30.50M$ -29.36M
EBITDA$ -39.83M$ -34.37M-$ -30.91M$ -29.89M
Net Income Common Stockholders$ -32.81M$ -43.31M$ -38.26M$ -30.50M$ -29.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 823.85M$ 423.60M$ 235.35M$ 252.70M$ 278.39M
Total Assets$ 868.85M$ 465.63M$ 280.26M$ 299.31M$ 324.52M
Total Debt$ 2.11M$ 2.54M$ 2.85M$ 3.25M$ 3.65M
Net Debt$ -821.73M$ -421.06M$ -232.50M$ -249.44M$ -274.74M
Total Liabilities$ 30.23M$ 36.46M$ 33.54M$ 21.77M$ 21.78M
Stockholders Equity$ 838.61M$ 429.17M$ 246.72M$ 277.54M$ 302.74M
Cash Flow-
Free Cash Flow$ -40.94M$ -33.20M-$ -27.61M$ -29.18M
Operating Cash Flow$ -40.60M$ -32.53M$ -19.00M$ -27.20M$ -28.60M
Investing Cash Flow$ -315.21M$ -171.16M$ 11.65M$ 1.16M$ 52.57M
Financing Cash Flow$ 436.11M$ 217.37M$ 257.00K$ 133.00K$ 694.00K
Currency in USD

Celldex Earnings and Revenue History

Celldex Debt to Assets

Celldex Cash Flow

Celldex Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis